News

As per the terms of collaboration agreement that signed on March 30, 2007, CanBas and Takeda’s wholly-owned subsidiary Millennium: The Takeda Oncology had jointly initiated Phase II trials

The court’s ruling narrowly defined several key phrases contained in Roquette’s patent claims, thereby dealing a significant blow to Roquette’s allegations of patent infringement. Reportedly, the court issued

Under the partnership, Proteo will offer USAMRIID with Elafin and related scientific data to plan and conduct preclinical research on the development of new therapeutic strategies to combat

Ricerca offers a spectrum of services for the areas of agrochemical registration, environmental analysis and preclinical discovery and development for biopharmaceutical registration. Ricerca holds a current DEA license

According to the Astellas, Mirabegron is a once daily oral ß3-adrenoceptor agonist discovered and developed by the company. Mirabegron enhances the urine collection function by activating ß3-adrenoceptor on

Before joining MonoSol Rx, Dr Norvitch held many executive level positions in pharmaceutical and specialty pharmaceutical organisations. Most recently, she built the US regulatory function for ProStrakan, a

Cyntellec has said that Mr Zarrabian has been consulting with the company and has been acting CEO since March of 2010. Previously, he served as president and COO

The study was conducted at The Ohio State University Comprehensive Cancer Center, Arthur James Cancer Hospital and Richard Solove Research Institute (OSUCCC-James). Arno said that the primary objective

The Amnis new option AutoSampler is expected to enhance productivity by enabling unattended sample loading from a wide variety of 96 well plates. The AutoSampler includes standard-height and